2nd ICPerMed Workshop “Personalised Medicine for All Citizens and Patients within Sustainable Implementation”
The 2nd ICPerMed Workshop will be organised by the Spanish ICPerMed member National Health Institute Carlos III (ISCIII) and will take place from November 5th-6th, 2019 in Madrid.
There will be high-level plenary sessions and four working groups. The working groups will meet in parallel and discuss the following topics:
Personalised medicine: How to ensure awareness and empowerment for all citizens?
Which are the Ethical, Legal and Social Implications (ELSI) of personalised medicine research and implementation?
Transfer of research results into the market: How to optimise a safe, fast and economic process to implement personalised medicine approaches?
Personalised medicine in the health system: How to ensure sustainability and an effective collaboration between all health care players as well as with prevention services?
Back to back with this event it will takes place:
– the Cluster event on Personalised Medicine with ITN funded projects, organised by the REA/EC, on November 6th-7th.
– the 1st EULAC PerMed Summer School, organised by the Italian Ministry of Health, on November 7th-8th.
Once identify and prepared an updated record of international/European patients’ organisations to be selected for patient representation, a document has been published with a list specifically relevant and with the bearing potential to contribute to ERA PerMed activities.
For the launch of the European project PEVOdata for Personalised Medicine (PM), Prof Christophe Le Tourneau, head of the Department of Drug Development and Innovation (D3i) at Curie Institute and project coordinator, hold a press conference on June 25th, 2019 in Paris (France). PEVOdata is funded by ERA PerMed for a period of 3 years in the first Joint Transnational Call (JTC) 2018 with a total budget of €1.54 million.
Deadline for pre-proposal submission is: 7 March 2019 (17:00 CET)
ERA PerMed is an ERA-NET Cofund, supported by 32 partners of 23 countries and cofunded by the European Commission (EC). To align national research strategies, promote excellence, reinforce the competitiveness of European players in Personalised Medicine (PM), and enhance the European collaboration with non-EU countries, 31 funding organisations have agreed to launch the second Joint Transnational Call for research projects in Personalised Medicine (PM). This represents the first of three potential additional calls non-cofunded by the EC. The funding organisations participating in this call particularly wish to promote innovative interdisciplinary collaboration and to encourage translational research proposals. The available budget for this call is 30 Mio € (approx.).
Opening of online submission tool: 9 January 2019
Submission deadline for pre-proposals: 7 March 2019 (17:00 CET)
Submission deadline for full-proposals: 17 June 2019 (17:00 CEST)